Explore By Subject Area   

Lead Editorial

Carl June and Daniel Chen on the Future of CAR-T, Cell Therapy, T-Cell Engagers and Synthetic Immunity

Carl June and Daniel Chen on the Future of CAR-T, Cell Therapy, T-Cell Engagers and Synthetic Immunity

Carl June, MD, University of Pennsylvania, delved into the current state of CAR T therapy, the lack of success in solid tumors, non-oncology endeavors, and more topics in a webinar moderated by Daniel S Chen, MD, PhD, Engenuity Life Sciences.

Read More

More Related Content

Editorial

Subscribe for More Information

Please provide your contact information and select areas of interest to receive updates.